Studies

Boston Scientific | MOAB | NCT06511141

Male Overactive Bladder

CG Oncology | CORE-008 | NCT06567743

High Risk Non-Muscle Invasive Bladder Cancer

CG Oncology | CRETO-EAP | NCT06443944

High Risk Non-Muscle Invasive Bladder Cancer

Dendreon ProvONE NCT06134232

Metastatic Castrate-Resistant Prostate Cancer

Ferring | ABLE-32 | NCT06510374

Intermediate Risk Non-Muscle Invasive Bladder Cancer

Laborie APEX | NCT06560476

Benign Prostatic Hyperplasia (“Enlarged Prostate”)

Procept BioRoboics | WATER IV | NCT06651632

Localized Prostate Cancer

Rivermark RAPID-III | NCT06849258

Benign Prostatic Hyperplasia (“Enlarged Prostate”)